Matthew S. Sussman

Matthew S. Sussman

Auto-generated profile, based on publicly available information

Matthew S. Sussman

University of Miami, Miller School of Medicine, Miami, FL

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Journal of Surgical Education
Verified
Journal Article
Closed access
HAHeidi Allespach
Heidi Allespach
MSMatthew Sussman
Matthew Sussman
JBJessica Bolanos
Jessica Bolanos
EAElias Atri
Elias Atri
CSCarl I Schulman
Carl I Schulman

1 December 2019 in Journal of Surgical Research
Verified
Journal Article
Closed access
MMMichelle B. Mulder
Michelle B. Mulder
SESarah A. Eidelson
Sarah A. Eidelson
MSMatthew S. Sussman
Matthew S. Sussman
CSCarl I. Schulman
Carl I. Schulman
ELEdward B. Lineen
Edward B. Lineen
KPKenneth G. Proctor
Kenneth G. Proctor

1 January 2022 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
MSMatthew S. Sussman
Matthew S. Sussman
EREmily L. Ryon
Emily L. Ryon
ABAmritpal Bahga
Amritpal Bahga
SAStephanie Almeida
Stephanie Almeida
JAJose I. Almeida
Jose I. Almeida

1 August 2018 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
HQHallie J. Quiroz
Hallie J. Quiroz
BWBrent A. Willobee
Brent A. Willobee
MSMatthew S. Sussman
Matthew S. Sussman
BFBradley R. Fox
Bradley R. Fox
CTChad M. Thorson
Chad M. Thorson
EPEduardo A. Perez
Eduardo A. Perez
Gastrointestinal stromal tumors are exceedingly rare tumors in the pediatric population, as a result many clinicians either may never see this diagnosis or will encounter it only a few times throughout their careers. It is imperative in the pediatric population to follow appropriate steps to ensure a swift diagnosis and referral to specialized centers that are equipped with the multidisciplinary teams accustomed to treating rare diseases. This review aims to discuss the most recent data available on the diagnostic modalities utilized in cases of suspected Pediatric GIST.

1 January 2020 in Journal of Surgical Research
Verified
Journal Article
Closed access
MMMichelle B. Mulder
Michelle B. Mulder
KKKristina C. Khazeni
Kristina C. Khazeni
MSMatthew S. Sussman
Matthew S. Sussman
JLJohn I. Lew
John I. Lew
JFJosefina C. Farrá
Josefina C. Farrá

1 August 2018 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
BWBrent A. Willobee
Brent A. Willobee
HQHallie J. Quiroz
Hallie J. Quiroz
MSMatthew S. Sussman
Matthew S. Sussman
CTChad M. Thorson
Chad M. Thorson
JSJuan E. Sola
Juan E. Sola
EPEduardo Alfonso Perez
Eduardo Alfonso Perez
Gastrointestinal stromal tumors (GIST) are exceedingly rare tumors in the pediatric population. As a result, many clinicians either may never see this diagnosis or will encounter it only a few times throughout their careers. Additionally, the more we discover about this disease, it becomes evident that it represents a distinct clinical entity from adult GIST. Many of the treatments and strategies used to combat the adult tumor are either ineffective or may be harmful to the pediatric population with this disease. The unique tumor biology found in pediatric GIST necessitates unique approaches and treatment strategies in order to achieve the best clinical outcome. This review aims to discuss the most recent data available on the different therapeutic modalities utilized in cases of Pediatric GIST.